Literature DB >> 19262121

Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process.

Enrique Arciniegas1, Luz M Carrillo, Juan B De Sanctis, Daniel Candelle.   

Abstract

The NFkappaB family of transcription factors, particularly the activated p50/p65 heterodimer, is expressed in vascular cells during intimal thickening formation when hemodynamic conditions are altered. Here, we report that p50, p65, IkappaBalpha and IKKalpha display different spatial and temporal patterns of expression and distribution during both chicken embryo aortic wall remodeling and intimal thickening development. Additionally, we show that both p50 and p65 were located in the nucleus of some mesenchymal cells expressing alpha-smooth muscle actin which are present in the spontaneous intimal thickening observed at embryonic days 12-14 of development. We also demonstrated that both NFkappaB subunits are present in monolayers of primary embryonic aortic endothelial cells attached to fibronectin and stimulated with complete medium. This study demonstrates for the first time the presence of activated NFkappaB during the remodeling of the embryonic aortic wall and the formation of intimal thickening, providing evidence that suggest a possible role for this transcription factor in the EndoMT process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19262121      PMCID: PMC2634999          DOI: 10.4161/cam.2.1.5789

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  51 in total

1.  Fluid shear stress activation of IkappaB kinase is integrin-dependent.

Authors:  I S Bhullar; Y S Li; H Miao; E Zandi; M Kim; J Y Shyy; S Chien
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

2.  I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain.

Authors:  P Crépieux; H Kwon; N Leclerc; W Spencer; S Richard; R Lin; J Hiscott
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway.

Authors:  P Kaliman; J Canicio; X Testar; M Palacín; A Zorzano
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

4.  Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors.

Authors:  T Nagel; N Resnick; C F Dewey; M A Gimbrone
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-08       Impact factor: 8.311

5.  Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.

Authors:  Subha Philip; Anuradha Bulbule; Gopal C Kundu
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Assessment of developmental changes in chicken and turkey insulin-like growth factor-II by homologous radioimmunoassay.

Authors:  J P McMurtry; R W Rosebrough; D M Brocht; G L Francis; Z Upton; P Phelps
Journal:  J Endocrinol       Date:  1998-06       Impact factor: 4.286

7.  Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.

Authors:  S Kuphal; I Poser; C Jobin; C Hellerbrand; A K Bosserhoff
Journal:  Oncogene       Date:  2004-11-04       Impact factor: 9.867

8.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Authors:  K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

9.  NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival.

Authors:  M Scatena; M Almeida; M L Chaisson; N Fausto; R F Nicosia; C M Giachelli
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

10.  Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B.

Authors:  C Rosette; M Karin
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  6 in total

Review 1.  "Venopathy" at work: recasting neointimal hyperplasia in a new light.

Authors:  Alexander S Yevzlin; Micah R Chan; Yolanda T Becker; Prabir Roy-Chaudhury; Timmy Lee; Bryan N Becker
Journal:  Transl Res       Date:  2010-08-13       Impact factor: 7.012

Review 2.  Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

3.  The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.

Authors:  Qiyu Tang; Andrew J McNair; Kanchan Phadwal; Vicky E Macrae; Brendan M Corcoran
Journal:  Front Cardiovasc Med       Date:  2022-05-17

4.  Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology.

Authors:  Claudio Derada Troletti; Ruud D Fontijn; Elizabeth Gowing; Marc Charabati; Bert van Het Hof; Imad Didouh; Susanne M A van der Pol; Dirk Geerts; Alexandre Prat; Jack van Horssen; Gijs Kooij; Helga E de Vries
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

5.  TLR2 regulates angiotensin II-induced vascular remodeling and EndMT through NF-κB signaling.

Authors:  Ke Lin; Wu Luo; Jueqian Yan; Siyuan Shen; Qirui Shen; Jun Wang; Xinfu Guan; Gaojun Wu; Weijian Huang; Guang Liang
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

6.  Ginsenoside Rg3 protects against iE-DAP-induced endothelial-to-mesenchymal transition by regulating the miR-139-5p-NF-κB axis.

Authors:  Aram Lee; Eunsik Yun; Woochul Chang; Jongmin Kim
Journal:  J Ginseng Res       Date:  2019-01-21       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.